Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
2.220
-0.140 (-5.93%)
At close: Dec 18, 2025, 4:00 PM EST
2.300
+0.080 (3.60%)
After-hours: Dec 18, 2025, 6:55 PM EST
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $77.8 million as of December 18, 2025. Its market cap has increased by 2,279.71% in one year.
Market Cap
77.80M
Enterprise Value
70.38M
1-Year Change
2,279.71%
Ranking
Category
Stock Price
$2.22
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has increased from $41.18M to $77.80M, an increase of 88.92%. That is a compound annual growth rate of 17.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 77.80M | 1,881.89% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
| Jan 12, 2022 | 41.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |